Related Experiment Video
Updated: Jun 8, 2025

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
BZW2 is a potential regulator of non-small cell lung cancer progression
Yan Mo1, Xueyong Feng1, Jincheng Su1
1Department of Cardiovascular Thoracic Surgery, The Second Affiliated Hospital of Guangxi Medical University, Nanning, China.
Background:
Personalized targeted therapy has become an important strategy for cancer treatment owing to its remarkable therapeutic efficacy and safety. However, drug resistance remains the primary cause of treatment failure. Basic leucine zipper and W2 domain 2 (BZW2), which is aberrantly expressed in cancer, has been implicated in tumor progression and may serve as a new therapeutic target. Therefore, the role of BZW2 in non-small cell lung cancer (NSCLC) requires further investigation.
Methods:
The expression and genetic alterations of BZW2 in pan-cancers were explored using The Cancer Genome Atlas (TCGA) PanCancer databases. The mRNA and protein levels of BZW2 in patients with NSCLC were verified in our cohort. Functional experiments including CCK8, colony formation, and transwell assays were performed to evaluate the impact of BZW2 on the proliferative, migratory, and invasive capacities of SK-MES-1 cells. Gene Set Enrichment Analysis was used to identify underlying biological processes and pathways. Single-cell RNA (scRNA) sequencing data were employed to investigate the tumor microenvironment of NSCLC and the co-expression of BZW2 and stemness-related genes.
Results:
Dysregulated BZW2 expression was observed in various malignant tumors. BZW2 expression was found to be significantly elevated in NSCLC. BZW2 depletion inhibited the growth, mobility, and invasive abilities of lung squamous cell carcinoma SK-MES-1 cells. BZW2 may be related to signaling pathways such as nucleotide excision repair, ubiquitin-mediated proteolysis, and the P53 signaling pathway. Biological processes, including translational initiation, tRNA processing, and RNA methylation, were observed to be enriched in the high-BZW2 group. Furthermore, there was a positive correlation between BZW2 and the m6A- and m5C-related genes. scRNA analysis revealed a co-expression relationship between BZW2 and stemness-related genes such as CD44, SOX9, and CD133.
Conclusions:
Elevated BZW2 expression is associated with the proliferation, migration, and invasion of NSCLC, and BZW2 may be a potential therapeutic target for NSCLC.
Insights
Basic leucine zipper and W2 domain 2 (BZW2) is elevated in non-small cell lung cancer (NSCLC), driving tumor growth and spread. Targeting BZW2 may offer a new therapeutic strategy for NSCLC patients.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genomics
Background:
- Drug resistance is a major challenge in personalized cancer therapy.
- Basic leucine zipper and W2 domain 2 (BZW2) is aberrantly expressed in cancer and linked to tumor progression.
- The role of BZW2 in non-small cell lung cancer (NSCLC) warrants further investigation.
Purpose of the Study:
- To investigate the expression and function of BZW2 in non-small cell lung cancer (NSCLC).
- To explore BZW2 as a potential therapeutic target for NSCLC.
Main Methods:
- Utilized The Cancer Genome Atlas (TCGA) PanCancer databases for BZW2 expression and genetic alterations.
- Performed in vitro functional assays (CCK8, colony formation, transwell) to assess BZW2's impact on NSCLC cells.
- Employed Gene Set Enrichment Analysis and single-cell RNA sequencing to analyze pathways and the tumor microenvironment.
Main Results:
- BZW2 expression is significantly elevated in NSCLC and associated with tumor progression.
- BZW2 depletion inhibited proliferation, migration, and invasion of lung squamous cell carcinoma cells.
- BZW2 correlates with stemness-related genes and pathways like P53 signaling and RNA methylation.
Conclusions:
- Elevated BZW2 expression promotes NSCLC proliferation, migration, and invasion.
- BZW2 represents a potential therapeutic target for non-small cell lung cancer.
More Related Videos
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
10:32Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
Published on: December 19, 2019
Related Concept Videos
Abnormal Proliferation
Non-Canonical Wnt Signaling Pathways
Negative Regulator Molecules
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
The Tumor Microenvironment
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...